Delivery Order SPE2DB24D2205-SPE2DB24FDXJV

Award Date 7/24/24
Potential Completion Date 8/14/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the supply of ESBRIET 267 MG TABLET 270S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order is for ESBRIET 267 MG TABLET 270S, a pharmaceutical product, with a completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2025, and is a firm fixed-price contract. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,311.50 firm fixed price contract is for the delivery of ESBRIET 801 MG TABLET 90S pharmaceutical product. The contract has an ultimate completion date of June 12, 2024 and was awarded on May 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,311.50 firm fixed price delivery order is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract, valued at $3,311.50, is a firm fixed-price delivery order with a completion date of November 27, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $9,934.50, is for the supply of the pharmaceutical product ESBRIET 801 MG TABLET 90S. This order is associated with Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 Firm Fixed Price Delivery Order contract is for the supply of ESBRIET 801 MG TABLET 90S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a firm fixed price of $3,311.50 and a completion date of March 18, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and does not have any major subcontractors listed. The contract was...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,425.95 firm fixed-price delivery order is for the supply of ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract has an ultimate completion date of April 30, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDXJV
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a for-profit organization and major pharmaceutical distributor. The $3,311.50 firm-fixed-price award is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of August 14, 2024. The contract has no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order is likely part of that broader IDC vehicle.

Generated 10/23/24, 9:22 AM